$2.2 million is not nearly enough to put om in a phase 3 trial but the $2.2 could be sufficient for CRO payment, Kevetrin Pill formulation and enough to pay for the production of Brilacidin for Phase 3 and maybe some satchets.

Leo said in a previous PR that he wanted BP to pay for all OM trial costs going forward. I guess it makes sense for Leo to produce and pay for the Brilacidin.